Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Articles

Page Path
HOME > Diabetes Metab J > Volume 45(5); 2021 > Article
Response
Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)
Chan-Hee Leeorcid
Diabetes & Metabolism Journal 2021;45(5):791-792.
DOI: https://doi.org/10.4093/dmj.2021.0190
Published online: September 30, 2021
  • 2,892 Views
  • 79 Download
  • 1 Scopus

Divisions of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Korea

Corresponding author: Chan-Hee Lee orcid Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 42415, Korea E-mail: chanheebox@naver.com

Copyright © 2021 Korean Diabetes Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

See the letter "Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction" on page 270.
We would like to thank Professor Kim for the interest in and comments regarding our study entitled, “Clinical impact of dysglycemia in patients with an acute myocardial infarction,” which was published in Diabetes and Metabolism Journal [1].
In our study, severe hyperglycemia (Group 5, >260 mg/dL) among acute myocardial infarction (AMI) patients was associated with a greater 30-day mortality in nondiabetics than in diabetics. A higher blood sugar level despite a lack of diabetes can indicate more extensive and serious myocardial damage based on higher troponin I and aspartate aminotransferase levels. I agree with your explanation regarding ‘paradoxical resistance’ of diabetic hearts to ischemia, which also can be explained by ‘ischemic preconditioning (IP)’ in diabetics. IP is the mechanism of protection in the heart in which ischemia paradoxically protects the myocardium against other ischemic insults [2,3].
As our study had different cut-off values for predicting 30-day mortality between diabetics and nondiabetics (208.5 and 174.5 mg/dL, respectively), I also agree with your suggestion that the optimal glucose level may vary between diabetic and non-diabetic patients with AMIs.
In a previous study about admission glucose level and mortality in the Korea Acute Myocardial Infarction Registry, hypoglycemia upon admission in AMI patients was related to a higher 30-day mortality [4]. Higher N-terminal pro-B-type natriuretic peptide level and E/E ratio in the hypoglycemia groups could be expected to be a poor prognosis; however, those results could not be represented in the hypoglycemia groups because of the limited number of patients in our study. Further, it was difficult to assess the relationships between hypoglycemia and myocardial injury and dysfunction.
We would like to thank Professor Kim again for the valuable comments on our findings. The noted limitation of our study will be identified through follow-up research to be conducted later.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

  • 1. Chung JW, Park YS, Seo JE, Son Y, Oh CW, Lee CH, et al. Clinical impact of dysglycemia in patients with an acute myocardial infarction. Diabetes Metab J 2021;45:270-4.ArticlePubMedPDF
  • 2. Rezende PC, Rahmi RM, Hueb W. The influence of diabetes mellitus in myocardial ischemic preconditioning. J Diabetes Res 2016;2016:8963403.ArticlePubMedPMCPDF
  • 3. Rezende PC, Rahmi RM, Uchida AH, da Costa LM, Scudeler TL, Garzillo CL, et al. Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients. Cardiovasc Diabetol 2015;14:66.ArticlePubMedPMCPDF
  • 4. Lee SA, Cho SJ, Jeong MH, Kim YJ, Kim CJ, Cho MC, et al. Hypoglycemia at admission in patients with acute myocardial infarction predicts a higher 30-day mortality in patients with poorly controlled type 2 diabetes than in well-controlled patients. Diabetes Care 2014;37:2366-73.ArticlePubMedPDF

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      • PubReader PubReader
      • ePub LinkePub Link
      • Cite this Article
        Cite this Article
        export Copy Download
        Close
        Download Citation
        Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

        Format:
        • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
        • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
        Include:
        • Citation for the content below
        Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4)
        Diabetes Metab J. 2021;45(5):791-792.   Published online September 30, 2021
        Close
      • XML DownloadXML Download
      Related articles
      Lee CH. Clinical Impact of Dysglycemia in Patients with an Acute Myocardial Infarction (Diabetes Metab J 2021;45:270-4). Diabetes Metab J. 2021;45(5):791-792.
      DOI: https://doi.org/10.4093/dmj.2021.0190.

      Diabetes Metab J : Diabetes & Metabolism Journal
      Close layer